AIMS/HYPOTHESIS: Obesity-induced inflammation is initiated by the recruitment of macrophages into adipose tissue. The recruited macrophages, called adipose tissue macrophages, secrete several proinflammatory cytokines that cause low-grade systemic inflammation and insulin resistance. The aim of this study was to find macrophage-recruiting factors that are thought to provide a crucial connection between obesity and insulin resistance. METHODS: We used chemotaxis assay, reverse phase HPLC and tandem MS analysis to find chemotactic factors from adipocytes. The expression of chemokines and macrophage markers was evaluated by quantitative RT-PCR, immunohistochemistry and FACS analysis. RESULTS: We report our finding that the chemokine (C-X-C motif) ligand 12 (CXCL12, also known as stromal cell-derived factor 1), identified from 3T3-L1 adipocyte conditioned medium, induces monocyte migration via its receptor chemokine (C-X-C motif) receptor 4 (CXCR4). Diet-induced obese mice demonstrated a robust increase of CXCL12 expression in white adipose tissue (WAT). Treatment of obese mice with a CXCR4 antagonist reduced macrophage accumulation and production of proinflammatory cytokines in WAT, and improved systemic insulin sensitivity. CONCLUSIONS/ INTERPRETATION: In this study we found that CXCL12 is an adipocyte-derived chemotactic factor that recruits macrophages, and that it is a required factor for the establishment of obesity-induced adipose tissue inflammation and systemic insulin resistance.
AIMS/HYPOTHESIS: Obesity-induced inflammation is initiated by the recruitment of macrophages into adipose tissue. The recruited macrophages, called adipose tissue macrophages, secrete several proinflammatory cytokines that cause low-grade systemic inflammation and insulin resistance. The aim of this study was to find macrophage-recruiting factors that are thought to provide a crucial connection between obesity and insulin resistance. METHODS: We used chemotaxis assay, reverse phase HPLC and tandem MS analysis to find chemotactic factors from adipocytes. The expression of chemokines and macrophage markers was evaluated by quantitative RT-PCR, immunohistochemistry and FACS analysis. RESULTS: We report our finding that the chemokine (C-X-C motif) ligand 12 (CXCL12, also known as stromal cell-derived factor 1), identified from 3T3-L1 adipocyte conditioned medium, induces monocyte migration via its receptor chemokine (C-X-C motif) receptor 4 (CXCR4). Diet-induced obesemice demonstrated a robust increase of CXCL12 expression in white adipose tissue (WAT). Treatment of obesemice with a CXCR4 antagonist reduced macrophage accumulation and production of proinflammatory cytokines in WAT, and improved systemic insulin sensitivity. CONCLUSIONS/ INTERPRETATION: In this study we found that CXCL12 is an adipocyte-derived chemotactic factor that recruits macrophages, and that it is a required factor for the establishment of obesity-induced adipose tissue inflammation and systemic insulin resistance.
Authors: Karl Balabanian; Bernard Lagane; Simona Infantino; Ken Y C Chow; Julie Harriague; Barbara Moepps; Fernando Arenzana-Seisdedos; Marcus Thelen; Françoise Bachelerie Journal: J Biol Chem Date: 2005-08-17 Impact factor: 5.157
Authors: D Zella; O Barabitskaja; L Casareto; F Romerio; P Secchiero; M S Reitz; R C Gallo; F F Weichold Journal: J Immunol Date: 1999-09-15 Impact factor: 5.422
Authors: W Blogowski; K Serwin; M Budkowska; D Salata; B Dolegowska; M Lokaj; P Prowans; T Starzynska Journal: J Biol Regul Homeost Agents Date: 2012 Oct-Dec Impact factor: 1.711
Authors: Frederic Sierro; Christine Biben; Laura Martínez-Muñoz; Mario Mellado; Richard M Ransohoff; Meizhang Li; Blanche Woehl; Helen Leung; Joanna Groom; Marcel Batten; Richard P Harvey; Carlos Martínez-A; Charles R Mackay; Fabienne Mackay Journal: Proc Natl Acad Sci U S A Date: 2007-09-05 Impact factor: 11.205
Authors: D Zella; O Barabitskaja; J M Burns; F Romerio; D E Dunn; M G Revello; G Gerna; M S Reitz; R C Gallo; F F Weichold Journal: Blood Date: 1998-06-15 Impact factor: 22.113
Authors: Daniel J Ceradini; Anita R Kulkarni; Matthew J Callaghan; Oren M Tepper; Nicholas Bastidas; Mark E Kleinman; Jennifer M Capla; Robert D Galiano; Jamie P Levine; Geoffrey C Gurtner Journal: Nat Med Date: 2004-07-04 Impact factor: 53.440
Authors: Elizabeth A Kirk; Zachary K Sagawa; Thomas O McDonald; Kevin D O'Brien; Jay W Heinecke Journal: Diabetes Date: 2008-02-11 Impact factor: 9.461
Authors: Naomi Van Gassen; Willem Staels; Eva Van Overmeire; Sofie De Groef; Mozhdeh Sojoodi; Yves Heremans; Gunter Leuckx; Mark Van de Casteele; Jo A Van Ginderachter; Harry Heimberg; Nico De Leu Journal: Stem Cells Transl Med Date: 2015-04-06 Impact factor: 6.940
Authors: Kevin Y Lee; Quyen Luong; Rita Sharma; Jonathan M Dreyfuss; Siegfried Ussar; C Ronald Kahn Journal: EMBO J Date: 2018-12-10 Impact factor: 11.598
Authors: Laura D Carbone; Petra Bůžková; Howard A Fink; John A Robbins; Monique Bethel; Mark W Hamrick; William D Hill Journal: Calcif Tissue Int Date: 2017-02-28 Impact factor: 4.333